ENADFENADFOTC
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank71
3Y CAGR-0.3%
5Y CAGR-22.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-0.3%/yr
vs -59.8%/yr prior
5Y CAGR
-22.6%/yr
Recent acceleration
Acceleration
+59.5pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 qtr
Consecutive growthRecovering
PeriodValue
Q4 202521.36%
Q3 2025-6.80%
Q2 2025-16.46%
Q1 2025-30.99%
Q4 202442.43%
Q3 202433.03%
Q2 2024-7.60%
Q1 2024-19.32%
Q4 2023-10.23%
Q3 20235.99%
Q2 2023-13.52%
Q1 20234.41%
Q4 202221.55%
Q3 2022-3.98%
Q2 20223.46%
Q1 2022-51.54%
Q4 2021129.85%
Q3 20216.50%
Q2 202126.61%
Q1 202155.69%
Q4 202076.95%
Q3 2020-20.16%
Q2 2020-11.22%
Q1 2020211.67%
Q4 2019-29.08%
Q3 2019416.51%
Q2 2019-8.15%
Q1 20190.00%
Q3 2018-27.85%
Q2 201825.50%
Q1 2018-13.95%
Q4 20170.00%
Q2 20176.88%
Q1 201713.95%
Q4 20160.00%